US federal health regulators say an experimental Covid-19 pill from Merck is effective but will seek input from outside experts on risks of birth defects and other problems during pregnancy.
The Food and Drug Administration (FDA) posted its analysis of the pill before a public meeting next week where academic and other experts will weigh in. The agency isn’t required to follow the group’s advice.
FDA scientists said their review had identified potential risks including possible toxicity and birth
Read more on theguardian.com